Back to RDEA Stock Lookup

RDEA – Analyst Comments

May 26, 2011 09:34 AM Jefferis Remains Positive on Shares of Ardea Biosciences (RDEA) Following 28-Week Extension Data For Lesinurad-Allopurinol Combination
Jan 7, 2011 11:50 AM Jefferies Raises Price Target on Ardea Biosciences (RDEA), Maintains Buy Rating
Jan 7, 2011 08:11 AM Global Hunter Securities reiterates a 'Buy' on Ardea Biosciences (RDEA); Positive top-line Phase IIb RDEA594 Data
Dec 10, 2010 09:27 AM Brean Murray Carret & Co. Raises Price Target on Ardea Biosciences (RDEA)
Nov 9, 2010 11:40 AM Jefferies Raises Ardea Biosciences's (RDEA) Price Target to $30, Maintains Rating at Buy
Jul 12, 2010 12:14 PM Leerink Swann Says M&A Is One Reason To Get Involved In Biophama (AGN, DNDN, BMRN, HGSI, more...)
Apr 1, 2010 02:26 PM Leerink Swann Reiterates an 'Outperform' on Ardea Biosciences (RDEA); Positive Phase IIb Data for RDEA594 Monotherapy De-Risks Gout Program
Apr 1, 2010 08:17 AM Soleil Securities Reiterates a 'Buy' Rating on Ardea Biosciences (RDEA)
Feb 19, 2010 11:45 AM Brean Murray Raises Price Target on Ardea (RDEA) to $23; Sees Phase 2b Trials on RDEA594 Proving It Is a 'Safe and Effective Drug'

Back to RDEA Stock Lookup